Kava has been part of Pacific life for centuries, long before anyone thought of it as an "export commodity." Today it sits at an interesting crossroads — a deeply traditional crop that is also attracting serious commercial attention from health and wellness markets around the world. Understanding how that trade actually works, and where the real opportunities and risks lie, is useful for anyone growing, processing, or exporting kava out of the Pacific.
A Beverage Rooted in Culture
Across the Pacific Island Countries, kava — made from a water extract of the root and rhizome of Piper methysticum — is far more than a drink. It is offered as a formal gesture of respect when entering a village or marking a significant occasion, and it remains a central part of everyday social life. The scale of this is easy to underestimate: in Vanuatu alone, an estimated 30,000 households are involved in growing kava, with a further 3,000 earning income directly from its trade and retail through kava bars. Fiji tells a similar story, with kava — known locally as yaqona — grown on more than 21,000 farms and worth an estimated FJD 66 million (AUD 42 million) a year. The domestic market is substantial too, considered as valuable as the export market.
Where Pacific Kava Travels
The main growing countries, Vanuatu and Fiji, export kava both within the Pacific and further afield — to New Zealand, New Caledonia, the United States, and parts of Asia, driven partly by demand from Pacific diaspora communities abroad. Most of this trade is still about kava as a beverage: dried roots and chips, sold largely in raw or semi-processed form.
But there's a second, potentially much larger market taking shape. Kava is rich in compounds called kavalactones, which are responsible for its relaxing, mildly soporific effect. Since the 1970s, the global nutraceuticals industry has recognised this and explored kava as a natural alternative to sleep aids and anti-anxiety medications. That interest has never fully gone away, and as the nutraceuticals sector continues to grow into a multi-billion-dollar global market, kava's potential role as an ingredient — not just a beverage — is arguably the biggest long-term opportunity for Pacific producers.
Quality Is the Whole Ballgame
If there's one theme that runs through the modern kava trade, it's quality — and the industry's history explains why. In the late 1990s, health concerns around kava consumption prompted several countries, particularly in Europe, to restrict or ban kava imports altogether. That damaged the industry's reputation for years. It wasn't until a 2007 World Health Organisation review concluded that kava consumed as a beverage causes no irreversible long-term health problems that the tide began to turn — Germany's courts overturned their long-standing import ban in 2015, reopening a market that had been closed for over a decade.
The underlying quality issue comes down to variety and processing. Kava varieties fall into two broad groups: noble and two-day, or tudei kava, distinguished by their kavalactone profiles. Noble varieties are the traditional, preferred choice for consumption. Tudei kava has become more common in some areas because it grows faster and tolerates dry conditions better — but it carries higher levels of flavokavins, compounds linked to toxic effects.
There's a second risk factor too: alkaloids that can develop in kava stems when they're exposed to sunlight, which is why peeling and proper processing of stem material matters. And regardless of variety, poor drying practice is its own hazard, since damp kava is prone to mould and aflatoxin contamination.
None of this is minor detail — it's the difference between a product that rebuilds market trust and one that risks another shutdown. Distinguishing noble from tudei kava, and processing and drying it correctly, is the foundation everything else in the trade is built on.
Two Industries, Two Snapshots
Fiji's yaqona industry is substantial and largely built on noble varieties — surveys of the country's major growing regions confirmed 13 commonly grown varieties, all classified as noble and suitable for human consumption, though production and processing methods vary noticeably by region. Export product is typically sold as powdered dried root (waka) and chips (lewena), alongside a smaller but growing range of value-added products like kava supplement drinks and capsules.
Vanuatu's kava industry is even larger in export terms — it's the country's third-largest export commodity, generating an estimated VUV 807 million (AUD 10 million) annually and supporting livelihoods across many of its islands, from direct chip exports to nakamal (kava bar) sales and the packaging and transport services built around them. Its kava chips find their way to New Caledonia, Fiji, the US, Guam, China, Kiribati, and New Zealand.
The Road Ahead
The direction of travel for the industry is fairly clear: better differentiation between noble and tudei varieties, stronger drying and processing standards, and clearer national and regional quality standards are what will keep export markets open and let producers command better prices. At the same time, the bigger prize — kava's role in the global nutraceuticals market — will depend on rebuilding buyer confidence through consistent quality, transparent kavalactone profiling, and traceability from farm to final product.
For producers thinking about the next decade of Pacific kava, that's really the opportunity in a sentence: the crop already has centuries of cultural weight behind it. What determines whether it also becomes a serious global commercial category is quality, consistency, and the ability to prove both — from the ground, all the way to the cup or the capsule.